<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment with recombinant tissue plasminogen activator (rt-PA) has been applied in <z:hpo ids='HP_0011009'>acute</z:hpo> cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> to reopen the occluded vessel and improve the patient's neurologic deficit </plain></SENT>
<SENT sid="1" pm="."><plain>However, the effect of this therapy on <z:e sem="disease" ids="C0876998" disease_type="Disease or Syndrome" abbrv="">intracardiac thrombus</z:e> has not been documented previously </plain></SENT>
<SENT sid="2" pm="."><plain>A forty-five-year-old man with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> developed <z:hpo ids='HP_0011009'>acute</z:hpo> cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> with disturbance of consciousness, right hemianopia, right <z:hpo ids='HP_0002301'>hemiplegia</z:hpo>, and global <z:hpo ids='HP_0002381'>aphasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Cerebral angiography demonstrated occlusion of the left middle cerebral artery trunk </plain></SENT>
<SENT sid="4" pm="."><plain>Intravenous administration of 30 megaunits (MU) of recombinant tissue plasminogen activator was commenced two hours after the ictus and completed within sixty minutes </plain></SENT>
<SENT sid="5" pm="."><plain>Cerebral angiography was repeated just after this treatment and demonstrated a new occlusion of the left intracranial internal carotid artery along with occlusion of a branch of the left external artery </plain></SENT>
<SENT sid="6" pm="."><plain>The authors subsequently performed two-dimensional echocardiography and found a mobile <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> in the left ventricle </plain></SENT>
<SENT sid="7" pm="."><plain>In patients with intracardiac mobile <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e>, recombinant tissue plasminogen activator seems to accelerate breakup or detachment of the <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> and subsequent recurrent embolization </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, it seems better to pay attention to the presence of mobile <z:e sem="disease" ids="C0876998" disease_type="Disease or Syndrome" abbrv="">intracardiac thrombus</z:e> before commencing intravenous infusion of rt-PA </plain></SENT>
</text></document>